$0.03
$-0.01 (-25.00%)
End-of-day quote: 04/04/2023
NasdaqGM:VIVO
Meridian Bioscience Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| TMO | Thermo Fisher Scientific | NYSE | Outperform | $584.05 | $591.94 | 0.00% | 1 | $222.94B |
| ROG | Roche Holding | SWX | Hold | CHF230.40 | CHF307.83 | 0.00% | 9 | CHF185.99B |
| DHR | Danaher | NYSE | Outperform | $262.78 | $260.33 | 0.00% | 4 | $194.64B |
| ABT | Abbott Laboratories | NYSE | Outperform | $103.95 | $118.92 | 0.00% | 7 | $180.83B |
| SIE | Siemens | XTRA | Outperform | 177.30€ | 178.14€ | 0.00% | 11 | 138.96€B |
| BDX | Becton Dickinson and Co | NYSE | Outperform | $228.79 | $284.47 | 0.00% | 8 | $66.12B |
| ILMN | Illumina | NasdaqGS | Outperform | $106.48 | $159.28 | 0.00% | 9 | $16.96B |
| BIM | bioMérieux | ENXTPA | Outperform | 95.65€ | 105.55€ | 0.00% | 1 | 11.73€B |
| TECH | Bio-Techne Corp | NASDAQ | Buy | $80.79 | $100.78 | 0.00% | 2 | $12.55B |
| MYGN | Myriad Genetics | NasdaqGS | Outperform | $23.16 | $22.08 | 0.00% | 8 | $1.79B |
| OSUR | OraSure Technologies | NasdaqGS | Hold | $4.85 | $7.40 | 0.00% | 4 | $406.27M |
| BCART | Biocartis Group NV | ENXTBR | - | 0.29€ | 1.10€ | 0.00% | 0 | 27.24€M |
| TRIB | Trinity Biotech | NasdaqGS | - | $1.69 | $3.00 | 0.00% | 0 | $16.00M |
| AXDX | Accelerate Diagnostics | NasdaqCM | Buy | $1.38 | $5.00 | 0.00% | 1 | $19.07M |
| OPGN | OpGen | NasdaqCM | $3.30 | $3.00 | 0.00% | 1 | $4.39M |
